{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:17:35Z","timestamp":1778678255612,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00115-026-01968-1","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:25:06Z","timestamp":1778675106000},"page":"219-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Twilight Zone revisited\u00a0\u2013 gelingt uns die Transition inzwischen besser?"],"prefix":"10.1007","volume":"97","author":[{"given":"Luise","family":"Poustka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Voderholzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"1968_CR1","doi-asserted-by":"crossref","unstructured":"Blum R, Garell D, Hodgman C, Jorissen T, Okinow N, Orr D, Slap G. Transitionfrom child-centered to adult health-care systems for adolescents with chronic conditions: a\u00a0position paper for the Society of Adolescent Medicine. J\u00a0Adolesc Health. 1993;14:570\u20136.","DOI":"10.1016\/1054-139X(93)90143-D"},{"key":"1968_CR2","doi-asserted-by":"crossref","unstructured":"Davis M,  Addressing the needs of youth in transition to adulthood. Adm Policy Ment Health. 2003;30(6):495\u2013509.","DOI":"10.1023\/A:1025027117827"},{"key":"1968_CR3","doi-asserted-by":"crossref","unstructured":"Paul M, Street C, Wheeler N, Singh SP. Transition to adult services for young people with mental health needs: a\u00a0systematic review. Clin Child Psychol Psychiatry. 2015;20(3):436\u2013457","DOI":"10.1177\/1359104514526603"},{"key":"1968_CR4","doi-asserted-by":"crossref","unstructured":"Santosh P, Adams L, Fiori F, Davidovi\u00c4\u2021 N, de Girolamo G, Dieleman GC, \u2026;MILESTONE Consortium. Protocol for the development and validation procedure of the managing the link and strengthening transition from child to adult mental health care (MILESTONE) suite of measures. BMC Pediatr. 2020 Apr 16;20(1):167","DOI":"10.1186\/s12887-020-02079-9"},{"key":"1968_CR5","unstructured":"Singh S,P, Paul M, Islam Z, Weaver T, Kramer T, et\u00a0al. Transition from CAMHS to Adult Mental Health Services (TRACK): A\u00a0Study of Service organisation, policies, process and user and Carer perspectives. In: Report for the National Institute for Health Research Service Delivery and Organisation programme (SDO project 08\/ 1613\/117); 2010."},{"key":"1968_CR6","doi-asserted-by":"crossref","unstructured":"Singh S.P. Transition of care from child to adult mental health services: the great divide. Curr Opin Psychiatry. 2009; 22:386\u2013390.","DOI":"10.1097\/YCO.0b013e32832c9221"},{"key":"1968_CR7","doi-asserted-by":"crossref","unstructured":"Singh SP, Paul M, Ford T, Kramer T, Weaver T. Transitions of care from child and adolescent mental health services to adult mental health services (TRACK study): a\u00a0study of protocols in greater London. BMC Health Serv Res. 2008;8(135):1\u20137.","DOI":"10.1186\/1472-6963-8-135"},{"key":"1968_CR8","doi-asserted-by":"publisher","unstructured":"Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G et\u00a0al. (2022): Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Molecular Psychiatry;27(1):281\u2013295. https:\/\/doi.org\/10.1038\/s41380-021-01161-7.","DOI":"10.1038\/s41380-021-01161-7"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01968-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-026-01968-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01968-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:25:15Z","timestamp":1778675115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-026-01968-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1007\/s00115-026-01968-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"23 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.\u00a0Poustka gibt folgende Interessenkonflikte an: Honorare (wissenschaftliche Beratung, Vortrag, Advisory Board in den letzten 5 Jahren): Infectopharm, Medice, Shire\/Takeda; finanzielle Zuwendungen (Drittmittel) f\u00fcr Forschungsvorhaben oder direkte Finanzierung von Mitarbeitern: EU, DFG, FWF und BMBF und Innovationsfond; keine Eigent\u00fcmerinteressen an Arzneimitteln\/Medizinprodukten; kein Besitz von Gesch\u00e4ftsanteilen, Aktien, Fonds; keine pers\u00f6nlichen Beziehungen zu einem Vertretungsberechtigten eines Unternehmens der Gesundheitswirtschaft. U.\u00a0Voderholzer: Angaben zu Drittmitteln: FIAT-Studie (Familien-Basierte telemedizinische versus Institutionelle Anorexia nervosa Therapie Studie), Krafft-Stiftung (Projekt Fr\u00fcherkennung Essst\u00f6rungen), Else-Kr\u00f6ner-Fresenius-Stiftung (Smartphone-basierte Nachsorge bei Essst\u00f6rungen); Vortragshonorare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}